Covista Inc.

NYSE:CVSA Stok Raporu

Piyasa değeri: US$4.2b

Covista Gelecekteki Büyüme

Future kriter kontrolleri 1/6

Covista kazanç ve gelirinin sırasıyla yıllık 12% ve 7.1% oranında artması tahmin edilirken, EPS'nin yıllık 14.4% oranında büyümesi bekleniyor.

Anahtar bilgiler

12.0%

Kazanç büyüme oranı

14.41%

EPS büyüme oranı

Consumer Services kazanç büyümesi13.0%
Gelir büyüme oranı7.1%
Gelecekteki özkaynak getirisin/a
Analist kapsamı

Low

Son güncelleme14 May 2026

Gelecekteki son büyüme güncellemeleri

Recent updates

Yeni Anlatı Apr 22

Health Care Workforce Shortages Will Pressure Capacity Expansion Yet Support Long Term Potential

Catalysts About Covista Covista is a health care education provider focused on training nurses, physicians, veterinarians and behavioral health professionals at scale. What are the underlying business or industry changes driving this perspective?
Yeni Anlatı Apr 08

Health Care Workforce Shortages And Digital Learning Will Support This Bullish Long Term Thesis

Catalysts About Covista Covista provides higher education programs focused on health care and related professional fields. What are the underlying business or industry changes driving this perspective?
Yeni Anlatı Mar 24

Health Care Workforce Shortages And Flexible Learning Will Support Stronger Long Term Outcomes

Catalysts About Covista Covista focuses on large scale health care education programs serving nursing, medical, veterinary and allied health students across the United States. What are the underlying business or industry changes driving this perspective?
Seeking Alpha Mar 13

Covista: A Mispriced Bet On The Healthcare Worker Shortage

Summary Covista is trading significantly below its intrinsic value despite short-term headwinds at Chamberlain University. All segments are growing revenue; Walden University’s 27% revenue and 13% enrollment growth offset Chamberlain’s 1% enrollment decline. Key risks include heavy reliance on Title IV funding and regulatory changes, though long-term healthcare demand and AI-driven career shifts support growth and limit risk. Read the full article on Seeking Alpha
Analiz Makalesi Sep 27

With EPS Growth And More, Adtalem Global Education (NYSE:ATGE) Makes An Interesting Case

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Analiz Makalesi Aug 07

Adtalem Global Education (NYSE:ATGE) Has A Pretty Healthy Balance Sheet

NYSE:ATGE 1 Year Share Price vs Fair Value Explore Adtalem Global Education's Fair Values from the Community and select...
Analiz Makalesi Jul 07

An Intrinsic Calculation For Adtalem Global Education Inc. (NYSE:ATGE) Suggests It's 44% Undervalued

Key Insights Adtalem Global Education's estimated fair value is US$221 based on 2 Stage Free Cash Flow to Equity...
Analiz Makalesi May 13

There's Reason For Concern Over Adtalem Global Education Inc.'s (NYSE:ATGE) Massive 27% Price Jump

Adtalem Global Education Inc. ( NYSE:ATGE ) shareholders have had their patience rewarded with a 27% share price jump...
Analiz Makalesi May 07

If EPS Growth Is Important To You, Adtalem Global Education (NYSE:ATGE) Presents An Opportunity

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analiz Makalesi Apr 24

Is Adtalem Global Education (NYSE:ATGE) A Risky Investment?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analiz Makalesi Mar 25

Adtalem Global Education Inc. (NYSE:ATGE) Shares Could Be 48% Below Their Intrinsic Value Estimate

Key Insights Adtalem Global Education's estimated fair value is US$198 based on 2 Stage Free Cash Flow to Equity...
Analiz Makalesi Mar 11

Subdued Growth No Barrier To Adtalem Global Education Inc.'s (NYSE:ATGE) Price

With a median price-to-earnings (or "P/E") ratio of close to 17x in the United States, you could be forgiven for...
Analiz Makalesi Feb 24

Is There Now An Opportunity In Adtalem Global Education Inc. (NYSE:ATGE)?

Adtalem Global Education Inc. ( NYSE:ATGE ), is not the largest company out there, but it saw a decent share price...
Seeking Alpha Feb 21

Adtalem Global Education: Surging On Registered Nurse Shortage

Summary Adtalem Global Education Inc.'s financial performance has surged with an underlying nationwide shortage of Registered Nurses and in mental health professionals. A shortage is expected to persist — Adtalem still looks to benefit from secular trends in an aging population, while the long-term performance depends on universities' ability to expand capacity. ATGE stock's surge already reflects a good mid-term earnings performance, making long-term growth required for significant returns. I estimate a fair value of $109.5. Read the full article on Seeking Alpha
Analiz Makalesi Jan 21

With EPS Growth And More, Adtalem Global Education (NYSE:ATGE) Makes An Interesting Case

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analiz Makalesi Dec 19

These 4 Measures Indicate That Adtalem Global Education (NYSE:ATGE) Is Using Debt Reasonably Well

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Seeking Alpha Dec 17

Adtalem Global Education Still Offers Competitive PEG Ratio And Substantial Share Buybacks

Summary The company has shown significant financial progress with improving EBIT and profit margins, indicating efficient cost management. Current valuation metrics suggest the company is rather cheaply priced, despite the good run in 2024. The future outlook remains positive, but investors should be aware of potential risks, such as the debt or future competitive threats from robotics. Read the full article on Seeking Alpha
Analiz Makalesi Nov 26

Adtalem Global Education Inc.'s (NYSE:ATGE) Shares Climb 27% But Its Business Is Yet to Catch Up

Adtalem Global Education Inc. ( NYSE:ATGE ) shareholders would be excited to see that the share price has had a great...
Analiz Makalesi Oct 31

Should You Think About Buying Adtalem Global Education Inc. (NYSE:ATGE) Now?

Adtalem Global Education Inc. ( NYSE:ATGE ), is not the largest company out there, but it led the NYSE gainers with a...
Analiz Makalesi Oct 16

Should You Be Adding Adtalem Global Education (NYSE:ATGE) To Your Watchlist Today?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Seeking Alpha Oct 04

Adtalem Global Education Faces Problems But Is Growing Steadily

Summary Adtalem Global Education focuses on medical and veterinary education, showing solid profitability and potential growth in a booming healthcare industry. Despite a current ratio below 1.0, ATGE maintains a reasonable price/book ratio and generates significant operating cash flow, indicating financial stability. Risks include reliance on government financial aid, maintaining accreditation, and ensuring student placements in healthcare jobs, which are crucial for sustaining reputation and revenue. With projected revenue growth and a forward P/E ratio of 13.12, Adtalem Global is a cautious buy, offering portfolio diversity in a growing sector. Read the full article on Seeking Alpha
Analiz Makalesi Sep 16

Adtalem Global Education (NYSE:ATGE) Seems To Use Debt Quite Sensibly

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analiz Makalesi Aug 29

Adtalem Global Education Inc.'s (NYSE:ATGE) Price In Tune With Earnings

With a price-to-earnings (or "P/E") ratio of 20.7x Adtalem Global Education Inc. ( NYSE:ATGE ) may be sending bearish...
Analiz Makalesi Aug 14

We Think Adtalem Global Education's (NYSE:ATGE) Robust Earnings Are Conservative

Even though Adtalem Global Education Inc.'s ( NYSE:ATGE ) recent earnings release was robust, the market didn't seem to...
Analiz Makalesi Jul 28

Should You Think About Buying Adtalem Global Education Inc. (NYSE:ATGE) Now?

While Adtalem Global Education Inc. ( NYSE:ATGE ) might not have the largest market cap around , it led the NYSE...
Seeking Alpha Jul 27

Adtalem Global Education: Still Undervalued After The Latest Rally

Summary Adtalem Global Education is set to report earnings on August 6th. The company specializes in healthcare education, with Chamberlain and Walden Universities under its wing, showing revenue growth post Walden acquisition. Financials show decent margins, but efficiency metrics trending down, with potential for top-line growth and margin expansion in the future. Read the full article on Seeking Alpha
Analiz Makalesi Jul 12

Does Adtalem Global Education (NYSE:ATGE) Deserve A Spot On Your Watchlist?

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Analiz Makalesi Jun 14

Adtalem Global Education (NYSE:ATGE) Has A Pretty Healthy Balance Sheet

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Seeking Alpha May 19

Adtalem Global Education: A Leading Healthcare Educator In A Growing Industry

Summary ATGE has demonstrated robust revenue growth and strong profit margins over the past three years. ATGE's 3Q24 earnings showed year-over-year revenue growth of 11.8%, driven by growth in enrollment and tuition rates. The healthcare industry is facing significant labour shortages, which are expected to impact hospitals growth targets and outlook. ATGE plays a crucial role in training and providing healthcare professionals. Read the full article on Seeking Alpha

Kazanç ve Gelir Büyüme Tahminleri

NYSE:CVSA - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
6/30/20282,2323243434442
6/30/20272,0622962973984
6/30/20261,9342492833574
3/31/20261,910250336406N/A
12/31/20251,889254368428N/A
9/30/20251,833247323379N/A
6/30/20251,788233288338N/A
3/31/20251,741229291338N/A
12/31/20241,688204234284N/A
9/30/20241,633172241290N/A
6/30/20241,585138247296N/A
3/31/20241,539111239278N/A
12/31/20231,496122196232N/A
9/30/20231,465108165196N/A
6/30/20231,451102166192N/A
3/31/20231,4477980108N/A
12/31/20221,442352551N/A
9/30/20221,447473161N/A
6/30/20221,382-36-2011N/A
3/31/20221,245-3566100N/A
12/31/20211,111-1595130N/A
9/30/2021977-26121153N/A
6/30/202189963152192N/A
3/31/2021943139106146N/A
12/31/2020984269141185N/A
9/30/20201,01624692140N/A
6/30/202086622068108N/A
3/31/20201,057208138182N/A
12/31/20191,04489N/A168N/A
9/30/20191,032130N/A174N/A
6/30/20191,014107N/A205N/A
3/31/20191,069169N/A184N/A
12/31/20181,121177N/A212N/A
9/30/20181,17584N/A227N/A
6/30/201896068N/A239N/A
3/31/20181,12467N/A244N/A
12/31/20171,14661N/A239N/A
9/30/20171,172119N/A222N/A
6/30/20171,208120N/A231N/A
3/31/20171,46759N/A178N/A
12/31/20161,60975N/A193N/A
9/30/20161,73117N/A210N/A
6/30/20161,080125N/A231N/A
3/31/20161,84537N/A213N/A
12/31/20151,86126N/A187N/A
9/30/20151,889119N/A179N/A
6/30/20151,910134N/A206N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: CVSA 'nin tahmini kazanç büyümesi (yıllık 12% ) tasarruf oranının ( 3.5% ) üzerindedir.

Kazançlar ve Piyasa: CVSA şirketinin kazançlarının (yıllık 12% ) US pazarından (yıllık 16.8% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: CVSA şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: CVSA şirketinin gelirinin (yıllık 7.1% ) US pazarından (yıllık 11.8% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Geliri: CVSA şirketinin gelirinin (yıllık 7.1% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: CVSA 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok


Büyüyen şirketleri keşfedin

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/05/27 23:28
Gün Sonu Hisse Fiyatı2026/05/27 00:00
Kazançlar2026/03/31
Yıllık Kazançlar2025/06/30

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
Önemli Gelişmeler10 yıl
  • Şirket duyuruları

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Covista Inc. 23 Bu analistlerden 4, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Gary BisbeeBarclays
Alexander ParisBarrington Research Associates, Inc.
Jeffrey SilberBMO Capital Markets Equity Research